logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Pharmacotherapy Of Pulmonary Hypertension 1st Edition Marc Humbert

  • SKU: BELL-4380882
Pharmacotherapy Of Pulmonary Hypertension 1st Edition Marc Humbert
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Pharmacotherapy Of Pulmonary Hypertension 1st Edition Marc Humbert instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 6.66 MB
Pages: 576
Author: Marc Humbert, David Montani, Oleg V. Evgenov, Gérald Simonneau (auth.), Marc Humbert, Oleg V. Evgenov, Johannes-Peter Stasch (eds.)
ISBN: 9783642386633, 9783642386640, 3642386636, 3642386644
Language: English
Year: 2013
Edition: 1

Product desciption

Pharmacotherapy Of Pulmonary Hypertension 1st Edition Marc Humbert by Marc Humbert, David Montani, Oleg V. Evgenov, Gérald Simonneau (auth.), Marc Humbert, Oleg V. Evgenov, Johannes-peter Stasch (eds.) 9783642386633, 9783642386640, 3642386636, 3642386644 instant download after payment.

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this area. The first part of the book covers the definition, classification, pathophysiology, pathology, biomarkers and animal models of the disease, thus laying the conceptual basis for what follows. The middle section provides an overview of the established therapies, such as calcium channel blockers, prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors and inhaled nitric oxide. The last section explores novel pathways and emerging therapeutic approaches including soluble guanylate cyclase stimulators, Rho-kinase inhibitors, inhibitors of serotonin receptors and transporters, peptide growth factors, vasoactive peptides, modulators of redox equilibrium and cyclic nucleotide homeostasis, as well as immunosuppressive and anti-proliferative agents. Particular attention is given to the clinical applications of these experimental therapies, that are on the horizon. The book thus spans the continuum from basic science to clinical applications.

Related Products